# Padagis Israel Pharmaceuticals Ltd. – FDA Inspection, Jun 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/padagis-israel-pharmaceuticals-ltd/cea75258-2067-4e78-8836-6dcb7ff06d23
Source feed: FDA_Inspections

> FDA inspection 1099381 of Padagis Israel Pharmaceuticals Ltd., June 13, 2019. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099381
- Company Name: Padagis Israel Pharmaceuticals Ltd.
- Inspection Date: 2019-06-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1220679 - 2023-09-20
- [FDA Inspection 1191880 - 2022-10-27](https://www.keypedia.com/records/fda_inspections/padagis-israel-pharmaceuticals-ltd/37421244-ea78-44bd-98ce-93597e9687f4)
- FDA Inspection 1065389 - 2018-07-19
- FDA Inspection 910286 - 2015-01-22
- FDA Inspection 837639 - 2012-08-27

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/padagis-israel-pharmaceuticals-ltd/e139fef4-b04f-4078-990f-6ffd56c549b9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c